| Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits J Böhme, N Martinez, S Li, A Lee, M Marzuki, AM Tizazu, D Ackart, ... Nature communications 11 (1), 5225, 2020 | 59 | 2020 |
| Aging, inflammaging and immunosenescence as risk factors of severe COVID-19 AM Tizazu, HM Mengist, G Demeke Immunity & Ageing 19 (1), 53, 2022 | 44 | 2022 |
| Metformin monotherapy downregulates diabetes-associated inflammatory status and impacts on mortality AM Tizazu, MSZ Nyunt, O Cexus, K Suku, E Mok, CH Xian, J Chong, ... Frontiers in physiology 10, 572, 2019 | 29 | 2019 |
| Baseline and early changes in laboratory parameters predict disease severity and fatal outcomes in COVID-19 patients A Gize, Y Belete, M Kassa, W Tsegaye, GB Hundie, BM Belete, M Bekele, ... Frontiers in Public Health 11, 1252358, 2023 | 2 | 2023 |
| Metformin enhances anti-mycobacterial responses by educating immunometabolic circuits of CD8+ T cells J Böhme, N Martinez, S Li, A Lee, M Marzuki, AM Tizazu, D Ackart, ... bioRxiv, 2020.08. 26.269217, 2020 | 1 | 2020 |
| Bacterial profile, drug resistance pattern, clinical and laboratory predictors of ascites infection in cirrhosis patients AS Helil, SA Haile, Y Birhanu, H Desalegn, DM Desalegn, RA Geremew, ... BMC Infectious Diseases 24 (1), 528, 2024 | | 2024 |
| Metformin Decreases Aging and Diabetes Associated Chronic Inflammation and has an Immunomodulatory Role AM Tizazu PQDT-Global, 2019 | | 2019 |
